InvestSMART

Stakk Limited (ASX:SKK)

ALERT: Price-sensitive ASX Announcement for SKK
Current share price for SKK : $0.026 0 (0%)+
Release
2 Jun 2026 9:02AM
Price at Release
$0.026
Full Release
download
Summary
Stakk Limited has secured a crucial client win in the U.S. healthcare sector, enhancing its annualised revenue run rate to A$26 million, a significant 2,067% increase since December 2024. The two-year agreement with a healthcare technology firm, expected to add A$3.85 million annually, focuses on deploying AI-native Digital Trust infrastructure. This solution addresses critical issues such as synthetic identities and real-time fraud orchestration across regulated industries. The first payment is due by 30 June 2026, affecting the financial year's cash position. The financial projections are derived from management accounts and internal data.
Key Points
  • Stakk Limited signs a new agreement with a U.S. healthcare technology customer contributing approximately A$3.85 million in annualised revenue.
  • The annualised revenue run rate increased by 2,067% to approximately A$26.0 million since December 2024.
  • The agreement includes a Master Services Agreement and Service Order Form with an initial term of two years.
  • The deployment involves implementing customised trust and decisioning workflows for healthcare-related services.
  • Stakk's strategy focuses on deploying an AI-native Digital Trust infrastructure across various regulated industries.
  • The company's platform addresses synthetic identities, manipulated digital signals, and real-time fraud orchestration.
  • First quarterly payment expected before 30 June 2026, impacting the Company’s FY26 cash position.
  • The financial metrics presented are based on unaudited management accounts and internal operating data.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.